Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Immunotherapy and Trophic Adrenocortical Stimulation in New Onset Autoimmune Addison's Disease
2012-001682-33Phase 2Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Jun 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab, methylprednisolone, tetracosactide hexaacetate in Addison's disease, sponsored by Newcastle Hospitals NHS Foundation Trust. Started Jun 2012; status: completed.
02
Drugs
rituximabmethylprednisolonetetracosactide hexaacetate
03
Conditions
Addison's disease
Beyond the preview
Go deeper on 2012-001682-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001682-33.